Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma — Stella

Recruiting

Back to Asthma trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Key details

Phase

Large-scale testing

Sponsor

Shanghai Mabgeek Biotech.Co.Ltd

Enrollment target

~504 participants

Started

March 2025

Primary completion

November 2027

Age range

12 Years – 75 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov